Proteolipid protein-deficient myelin promotes axonal mitochondrial dysfunction via altered metabolic coupling. by Yin, Xinghua et al.
UC San Diego
UC San Diego Previously Published Works
Title
Proteolipid protein-deficient myelin promotes axonal mitochondrial dysfunction via altered 
metabolic coupling.
Permalink
https://escholarship.org/uc/item/8nq0026k
Journal
The Journal of cell biology, 215(4)
ISSN
0021-9525
Authors
Yin, Xinghua
Kidd, Grahame J
Ohno, Nobuhiko
et al.
Publication Date
2016-11-01
DOI
10.1083/jcb.201607099
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
JCB: Article
JCB 531
The Rockefeller University Press  $30.00
J. Cell Biol. Vol. 215 No. 4 531–542
https://doi.org/10.1083/jcb.201607099
Introduction
Myelin insulates nerve fibers and promotes rapid propagation of 
action potentials. In addition to its role in nerve conduction, my-
elin facilitates the long-term survival of axons (Nave and Trapp, 
2008). Loss or disruption of this myelin-trophic support results 
in axonal degeneration, which is the major cause of permanent 
neurological disability in inherited and acquired diseases of 
myelin (Trapp and Nave, 2008). Experimental manipulations of 
myelin gene expression have established that individual myelin 
proteins play essential roles in providing axonal trophic sup-
port and that these trophic functions are independent of any role 
these proteins play in myelin formation. Null mutations of the 
myelin-associated glycoprotein (MAG; Yin et al., 1998), prote-
olipid protein (PLP; Griffiths et al., 1998), and 2′,3′-cyclic nu-
cleotide 3′-phosphodiesterase (CNP; Lappe-Siefke et al., 2003) 
cause axonal degeneration. MAG and CNP deletions have 
little, if any, effect on central nervous system (CNS) myelin-
ation, whereas the PLP-null CNS is hypomyelinated. Axonal 
pathologies that precede axonal degeneration include altered 
axonal transport and axonal ovoid formation in PLP- and CNP-
null mice (Griffiths et al., 1998; Lappe-Siefke et al., 2003) and 
reduced neurofilament phosphorylation and smaller axonal di-
ameters in MAG-null mice (Yin et al., 1998). These pathologies 
are most prominent in paranodal regions of the myelin internode, 
where myelin–axonal communication is most likely to occur.
Hereditary spastic paraplegia (HSP) is a diverse group 
of genetic disorders with a common clinical feature of lower 
limb spasticity caused by degeneration of long CNS axons. 
Over 70 HSP gene loci have been identified, and 22 HSP-caus-
ing genes have been cloned (Blackstone, 2012; Novarino et al., 
2014). Whole exome sequencing and protein network analysis 
identified 18 additional gene candidates for HSP (Novarino et 
al., 2014). Proteins encoded by most of these HSP genes are 
enriched in axons, where they participate in mitochondrial 
function (DiMauro et al., 2013), fast axonal transport (Saugier- 
Veber et al., 1994; Edgar et al., 2004), ER morphogenesis/func-
tion (Rismanchi et al., 2008; Montenegro et al., 2012), purine 
metabolism (Akizu et al., 2013), and membrane trafficking 
(Wright et al., 2011). Four HSP-associated genes (PLP, fatty 
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acid 2-hydroxylase, connexin 47, and MAG) are enriched in 
myelinating oligodendrocytes (Novarino et al., 2014). PLP is 
the most abundant protein in CNS myelin. Deletions and point 
mutations of the PLP gene cause HSP2 (Saugier-Veber et al., 
1994; Starling et al., 2002; Edgar et al., 2004; Inoue, 2005). 
Mice null for PLP develop a late-onset (>12 mo) axonal de-
generation characterized by altered axonal transport and axo-
nal ovoids that initially accumulate in juxtaparanodal axoplasm 
(Griffiths et al., 1998). We generated a mutant mouse model 
(referred to as P0-CNS mice) in which PLP is replaced with 
P0 protein, the major structural protein of peripheral nervous 
system myelin. P0-CNS and PLP-null optic nerves display sim-
ilar axonal pathology (Griffiths et al., 1998; Edgar et al., 2004; 
Yin et al., 2006). Compared with PLP-null mice, P0-CNS mice 
have shorter myelin internodes, more paranodal axoplasm, in-
creased axonal pathology, increased neurological disability, and 
less than half the life span of PLP-null mice (Yin et al., 2006). 
P0-CNS mice, therefore, develop an accelerated form of HSP2, 
where axonal structural pathology is prominent by 6 mo of age. 
Although experimentally induced P0-CNS mice display many 
of the pathological and clinical features of HSP, there is no nat-
urally occurring mammalian counterpart. Because of the rapid 
progression of axonal pathology, P0-CNS mice provide a more 
convenient HSP animal model than the original PLP-null mice 
and were used in this study.
Although little is known about the mechanisms underly-
ing myelin-induced axon ovoid formation, an imbalance be-
tween axonal energy supply and demand has been postulated to 
cause axonal degeneration in primary diseases of myelin (Trapp 
and Stys, 2009; Campbell and Mahad, 2012). Because of their 
length, axons must depend on their local environment for en-
ergy substrates. Up to 98% of the axonal surface is covered by 
myelin. Therefore, the oligodendrocyte is a likely source of 
axonal ATP substrates. Recent studies support the concept that 
oligodendrocytes transfer ATP substrates to axons via mono-
carboxylate transporter 1 (MCT1), which is enriched in paran-
odal regions of the myelin internode (Lee et al., 2012; Morrison 
et al., 2013; Saab et al., 2013, 2016). In the present study, we 
find that mitochondrial dysfunction/degeneration and reduced 
axonal ATP production are prominent features of axonal pathol-
ogy in P0-CNS mice. Because P0-CNS mice have clinical and 
pathological phenotypes similar to those caused by mutations 
in proteins enriched in or associated with axonal mitochondria 
and smooth ER (SER), our experiments suggest that reduced 
mitochondrial function in juxtaparanodal axoplasm may be a 
convergent mechanism of axonal degeneration in many forms 
of HSP and possibly other neurodegenerative diseases.
Results
Axonal mitochondria in P0-CNS axons
We used serial blockface scanning 3D EM to reconstruct seg-
ments of 1-mo-old wild-type (WT; Fig. 1, A–C) and P0-CNS 
(Fig.  1, D–F) optic nerve axons at nanometer resolution. We 
reconstructed axonal mitochondria (Fig. 1, C and F; individual 
mitochondria are displayed as different colors) and compared 
their numbers and sizes in juxtaparanodal axoplasm (mitochon-
dria within 15 µm of nodes) and internodal axoplasm (located 
>15 µm from the node). Compared with WT axons, there was 
a significant increase (approximately twofold) in the number 
of juxtaparanodal mitochondria in P0-CNS axons (Fig.  1  G). 
The number of internodal mitochondria was similar in P0-CNS 
and WT axons (Fig. 1 G). Individual mitochondria in both jux-
taparanodal and internodal P0-CNS axoplasm, however, were 
significantly shorter (Fig.  1  H) and slightly thicker (Fig.  1  I) 
when compared with WT mitochondria. Compared with WT 
axons, the volume of individual mitochondria in P0-CNS fibers 
was decreased by ∼50% in juxtaparanodal axoplasm (Fig. 1 J). 
Because of increased mitochondrial numbers, however, total 
mitochondrial volume was significantly increased in P0-CNS 
juxtaparanodal axoplasm when compared with mitochondrial 
volume in WT juxtaparanodal axoplasm (Fig. 1 K).
Because axonal pathology is most prominent in distal jux-
taparanodes of adult P0-CNS axons (Yin et al., 2006), we com-
pared mitochondrial numbers and axonal diameters in distal and 
proximal juxtaparanodal axoplasm in 1-mo-old WT (Fig. 2 A) 
and P0-CNS optic nerve fibers (Fig. 2 B). Mitochondrial numbers 
(Fig. 2 C) and axonal diameters (Fig. 2 D) were significantly 
increased in P0-CNS distal juxtaparanodal axoplasm when com-
pared with WT distal juxtaparanodal axoplasm. Similar, but less 
dramatic, changes in mitochondrial numbers were present in 
proximal juxtaparanodal axoplasm (Fig. 2 C). The increase in 
distal juxtaparanodal axon diameter correlated with the position-
ing of mitochondria beneath the axolemma (Fig. 2 B). In 1-mo-
old P0-CNS axons, mitochondria did not accumulate beneath 
Schmidt-Lanterman incisures (SLIs; Fig. S1, A and B), which 
form in P0-CNS internodes (Yin et al., 2008), nor were they 
accompanied by accumulations of vesicles and dense bodies, 
which were present in 6-mo-old P0-CNS mice (Fig. S1 C). We 
next asked whether mitochondria in 1-mo-old P0-CNS axons dis-
played ultrastructural changes associated with dysfunction and/
or degeneration and whether these changes were more prominent 
in juxtaparanodal axoplasm than in internodal axoplasm. Mito-
chondria were binned into four groups: elongated with normal 
cristae (Fig. 2 E), round with normal cristae (Fig. 2 F), round with 
reduced/abnormal cristae (Fig. 2 G), and round with few or no 
cristae (Fig. 2 H). There was little difference in the distributions 
of mitochondrial morphologies in the internodal and juxtaparan-
odal axoplasm of WT myelinated fibers or in the internodal 
axoplasm of P0-CNS myelinated fibers (Fig. 2 I). Elongated mi-
tochondria comprised ∼70% of the mitochondria in both inter-
nodal (69%) and juxtaparanodal (73%) regions of WT axoplasm. 
16% were round with normal cristae, and 11% were round with 
reduced or absent cristae. In 1-mo-old P0-CNS juxtaparanodal 
axoplasm, only 22% of mitochondria were elongated, 44% were 
round with normal cristae, and 34% were round with reduced or 
absent cristae (Fig. 2 I). These data establish that mitochondrial 
pathology is a prominent feature in juxtaparanodal axoplasm 
from 1-mo-old P0-CNS myelinated fibers. We also considered 
whether microtubule (MT) loss in juxtaparanodal axoplasm may 
have accounted for mitochondrial accumulation in 1-mo-old P0-
CNS axons. WT juxtaparanodal/nodal axoplasm (Fig. 2 J) and 
the core of the P0-CNS juxtaparanodal/nodal axoplasm (Fig. 2 K) 
contained similar MT orientations (Fig. 2, J and K, green lines) 
and MT densities (Fig. 2 L). Thus, disassembly of MTs does not 
appear to be responsible for mitochondrial accumulation and dis-
placement in 1-mo-old P0-CNS juxtaparanodal axoplasm.
Mitochondrial outer membrane extensions 
and SER associations are altered in 
P0-CNS axons
Mitochondria and SER interact morphologically and func-
tionally (Hayashi et al., 2009). To date, knowledge of the 3D 
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distribution of SER in WT nerves is limited, and studies have 
not examined whether axonal SER or mitochondria–SER as-
sociations are altered in myelin diseases. To investigate the in-
tegrity of the SER network and its physical association with 
mitochondria, we traced SER and mitochondria in serial 3D 
EM images from 1-mo-old WT (Fig.  3, A–C) and P0-CNS 
(Fig. 3, D–F) myelinated optic nerve axons. Axonal SER cis-
ternae formed a continuous and highly branched network of 
tubular structures (10–30 nm wide) in WT myelinated axons 
(Fig. 3 B). The overall distribution/density of SER was similar 
in WT (Fig. 3 B) and P0-CNS (Fig. 3 E) axons, with ∼3–4 µm 
of SER length per micrometer cubed of axoplasm (Fig. 3 G). 
The SER in P0-CNS axons, however, was often fragmented and 
was not as continuous as WT axonal SER (Fig. 3 E). Blunt ends 
of SER tubules were increased 2.3-fold in the juxtaparanodal 
axoplasm of P0-CNS fibers (Fig. 3 H).
We next compared the relationship between SER and mi-
tochondria in WT (Fig. 3, I and J) and P0-CNS (Fig. 3, K and L) 
axons and measured the length of SER that apposed the mito-
chondrial outer membrane by <50 nm (Fig. 3, M–Q). In addition 
to SER–outer membrane associations on the main body of the 
mitochondrion, 3D reconstructions identified lateral extensions 
of the mitochondrial outer membrane (Fig. 3 I, arrows). These 
extensions had a luminal diameter of ∼120 nm (Fig. 3 I), and 
mitochondrial inner membranes were rarely present. Approxi-
mately 70% of the mitochondria in 1-mo-old WT optic nerves 
had mitochondrial outer membrane extensions (Fig. 3, I and J), 
which increased total mitochondrial length by ∼66% (Fig. S2 
A). The median mitochondrial length was ∼1.7 µm (Fig. 1 H), 
whereas the median length of mitochondrial outer membrane 
extensions was ∼1.2 µm (Fig. 3 N). Three quarters of elongated 
mitochondria had extensions, as did half of the round mito-
chondria with normal cristae (Table S1). Approximately 10% 
of round mitochondria with reduced or absent cristae had ex-
tensions. Compared with WT axons, there was a 47% reduction 
in the percentage of P0-CNS internodal mitochondria with outer 
membrane extensions (Fig. 3 M) and a 69% decrease in the num-
ber of juxtaparanodal mitochondria with extensions (Fig. 3 M). 
Mitochondrial outer membrane extensions were significantly 
shorter in P0-CNS juxtaparanodal axoplasm (Fig. 3 N).
In WT axons, the total SER on mitochondria was slightly 
greater for juxtaparanodal mitochondria (2.4-µm median length) 
than for internodal mitochondria (1.7-µm median length; 
Fig.  3  O). In WT juxtaparanodal axoplasm, 1.8 µm of SER 
Figure 1. Mitochondria in 1-mo-old WT and P0-CNS optic nerve axons. (A–F) 3D EM reconstructions of 1-mo-old WT (A–C) and P0-CNS (D–F) optic nerve 
segments showing 3D organization of fibers (A and D), a single-slice view of a myelinated axon (B and E), and 3D reconstructions of mitochondria in single 
axons (C and F; individual mitochondria are shown as different colors). Bars, 1 µm. m, mitochondria. (G) Mitochondrial numbers were increased in P0-
CNS juxtaparanodal axoplasm and were similar in WT and P0-CNS internodal axoplasm. (H and I) Compared with mitochondria in WT axons, individual 
mitochondria in P0-CNS axons were significantly shorter (H) and slightly thicker (I). (J) The volumes of individual mitochondria were decreased in P0-CNS 
juxtaparanodal axoplasm and internodal axoplasm. (K) Total mitochondrial volumes were increased in P0-CNS juxtaparanodal axoplasm and were similar 
in WT and P0-CNS internodal cytoplasm. Jxpn, juxtaparanodal; Ax, axon; P, paranode; N, node. (G–K) Bar, median; box, 25–75%; whiskers show range; 
**, P < 0.01; ***, P < 0.001; WT versus P0-CNS, Wilcoxon signed-rank test with Bonferroni’s correction for multiple comparisons. Data were pooled for 
mitochondria (H–J, n = 44, 115, 210, and 198) and axons (G and K, n = 19, 22, 37, and 40) from three animals for analysis.
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(median length) was associated with the body of the mitochon-
dria (Fig. 3 P), and 0.6 µm was associated with mitochondrial 
outer membrane extensions (Fig.  3  Q). Total SER associated 
with mitochondria was significantly reduced in both P0-CNS 
internodal (1.0-µm median value) and juxtaparanodal (0.5-µm 
median value) axoplasm (Fig. 3 O). In P0-CNS juxtaparanodal 
axoplasm, SER associated with mitochondria was reduced by 
86% (Fig. 3 O). SER associated with the mitochondrial body 
(0.6 µm) was reduced by 66% (Fig. 3 Q and Fig. S2 B), and 
SER associated with mitochondrial outer membrane extensions 
were reduced by almost 100% (Fig. 3 P and Fig. S2, C and D). 
As shown schematically in Fig.  3  R (a), extensions on mito-
chondria provide an increased interface for mitochondrial outer 
membrane–SER associations. The smaller luminal diameter of 
the extensions may also provide a higher surface area to volume 
ratio for molecular exchange than on the mitochondrial body 
(Fig.  3  R, b). Reductions in mitochondrial length and outer 
membrane extension size in rounded mitochondria (Fig. 3 R, 
c and d) decrease mitochondria–SER associations in P0-CNS 
axons. Fragmentation of the SER (Fig. 3 R, e) further reduces 
mitochondria–SER associations and disrupts SER continuity.
Axonal function and ATP production
To investigate whether reduced ATP production is associated 
with mitochondrial degeneration and reduced mitochondria–
SER associations in P0-CNS optic nerves, we compared 1-mo-
old WT and P0-CNS nerves. The drop in ATP levels (Fig. 4 B, 
orange) was further validated in experiments where optic nerves 
were exposed to a metabolic challenge caused by oxygen-glu-
cose deprivation (OGD; Fig.  4  A). Optic nerve function was 
monitored quantitatively as the area under the supramaximal 
compound action potential (CAP). The CAP area is propor-
tional to the total number of excited axons and represents a 
convenient and reliable means of monitoring optic nerve axon 
function (Cummins et al., 1979; Stys et al., 1991). When chal-
lenged with 30 min of OGD, P0-CNS optic nerves (Fig. 4 A, 
orange circles) show an accelerated loss of function (Fig. 4, A 
and E; 20 min for P0-CNS and 30 min for control, P = 0.008) 
compared with control nerves (Fig. 4 A, green circles). There 
was also a statistically significant reduction (P = 0.03) in the 
percentage of P0-CNS axons recovering from 30 min of OGD 
(Fig. 4 A, inset). The rapid loss of axon function and the re-
duction in nerve function recovery are most likely caused by 
decreased ATP production, as previously shown (Baltan et al., 
2008; Baltan, 2009), and not by glutamate excitotoxicity be-
cause 30 min of OGD leads to minimal glutamate accumulation 
(Tekkök et al., 2007).
Mitochondrial transport in P0-CNS axons
The accumulation of organelles in axonal ovoids in PLP-null 
and P0-CNS axons has been associated with impaired axonal 
transport (Griffiths et al., 1998; Edgar et al., 2004; Yin et al., 
Figure 2. Mitochondrial pathology and MT distribution in juxtaparanodal regions of 1-mo-old P0-CNS optic nerve axons. (A) An electron micrograph 
shows a mitochondrion in WT juxtaparnodal axoplasm. (B) Mitochondria accumulated in P0-CNS juxtaparanodal axoplasm and were positioned beneath 
the axolemma. (C and D) Mitochondrial numbers (C) and axonal diameters (D) were similar in WT proximal and distal juxtaparanodal axoplasm (A). 
Compared with WT axons, mitochondrial numbers (C) were increased in P0-CNS juxtaparanodal axoplasm, and this resulted in increased axonal diameters 
(D). These increases were greater in distal compared with proximal juxtaparanodal axoplasm (B–D). (E–H) Mitochondrial morphology was binned into 
elongated with normal cristae (E), rounded with normal cristae (F), rounded with reduced cristae (G), and round with sparse or no cristae (H). (I) Most WT 
and internodal P0-CNS mitochondria were elongated, but most P0-CNS juxtaparanodal mitochondria were rounded with increased frequency of disrupted 
cristae. (J and K) MTs were traced in WT (J, green overlay) and P0-CNS juxtaparanodal axoplasm (K, green overlay). Bars, 0.5 µm. (L) MT density was 
similar in WT and the core of P0-CNS juxtaparanodal axoplasm. MTs were rarely detected in the swollen axoplasm that contained displaced mitochondria 
(B and K). m, mitochondria. (C, D, and L) Mean ± SEM of axonal values from three animals; *, P < 0.05; **, P < 0.02; t test. 
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2006). We compared axonal mitochondrial distribution and 
transport in myelinated organotypic slice cultures from WT 
and P0-CNS cerebella (Fig.  4, C–F) as described previously 
(Ohno et al., 2011). Time-lapse images of fluorescently tagged 
Mito-Dendra2–positive axonal mitochondria were recorded in 
myelinated Purkinje cell axons, and kymographs of stationary 
and motile mitochondria were generated (Fig. 4, C’, C”, D’, and 
D”). After live imaging, cultures were fixed, and nodal regions 
of the imaged axons were delineated by immunostaining for 
Caspr and registered with live imaging of the same fiber (Fig. 4, 
Figure 3. Mitochondria–SER associations and mitochondrial outer membrane extensions in 1-mo-old WT and P0-CNS optic nerve axons. (A–F) Images 
of 1-mo-old WT (A–C) and P0-CNS (D–F) optic nerves showing a single-slice view of myelinated axons by EM (A and D), 3D projections of SER (B and E), 
and individual mitochondria (C and F, multiple colors). m, mitochondria. (G and H) SER length relative to axonal volume was similar in WT and P0-CNS 
juxtaparanodal and internodal regions. (H) However, the number of SER termini per micrometer cubed of the axon was 2.5-fold greater in P0-CNS juxtaparan-
odal regions. (I and J) Extensions of the mitochondrial outer membranes occurred at the longitudinal ends of WT mitochondria (I, arrows). The SER closely 
apposed WT mitochondria and outer membrane extensions in single EM slices (I, arrowheads), and this association was fully delineated by 3D reconstruction 
of segmented SER (J, green) and mitochondria (J, red). (K and L) Mitochondria in P0-CNS juxtaparanodal axoplasm rarely extended outer membranes, and in 
3D reconstructions (L), the surrounding SER was fragmented. (M) The percentage of mitochondria with outer membrane extensions was significantly reduced 
in P0-CNS juxtaparanodal and internodal axoplasm. (N) SER associations with mitochondria were reduced in P0-CNS juxtaparanodal axoplasm (P < 0.002). 
When present, outer membrane extensions in P0-CNS juxtaparanodal axoplasm were significantly shorter than outer membrane extensions in WT mitochondria 
or in P0-CNS internodal mitochondria (includes mitochondria with lengths of zero). (O) Total SER associated with mitochondria was greater in WT than in P0-
CNS axons. (P and Q) SER associated with the mitochondrial body (P) and outer membrane extensions (Q) was extensive in WT axoplasm but was reduced 
in P0-CNS juxtaparanodal mitochondria (P) and was rare on extensions (Q). (R) Optic nerve axons contained elongated mitochondria with outer membrane 
extensions that increased mitochondrial length by two thirds and provided an interface for SER interaction (a). SER–mitochondrial outer membrane extensions 
(a) had a higher surface area to volume ratio than the main mitochondrion (b). In P0-CNS, increased proportions of rounded mitochondria with shorter or 
absent extensions (c) and SER fragmentation (e) reduced SER associations. (G, H, and M) Mean ± SEM; t test; means of three animals (1,528 mitochondria). 
(N–Q) Box plots: bar, median; box, 25–75%; whiskers, 97.5–2.5%. Wilcoxon signed-rank test with Bonferroni’s correction; mitochondria (n = 28, 42, 63, 
and 62) pooled from three animals. *, P < 0.05; **, P < 0.01; ***, P < 0.005. Bars: (A–F) 1 µm; (I–L) 0.5 µm.
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C and D). Large stationary mitochondria did not translocate in 
either the anterograde or retrograde directions (Fig. 4, C” and 
D”, vertical stripes). Compared with WT axons, the mean trans-
port speed of small motile mitochondria in P0-CNS axons was 
reduced by 40% over the total length of the axon (Fig. 4 E, All), 
by 38% in internodal axoplasm (Fig. 4 E, Inter), and by 50% in 
nodal–juxtaparanodal axoplasm (Fig. 4 E, N-PN). Motile mito-
chondria preferentially stopped in the proximal juxtaparanodal 
region in WT axons (Fig. 4 F). In contrast, motile mitochondria 
preferentially slowed or stopped in the distal juxtaparanodal re-
gion in P0-CNS axons (Fig. 4 F). These results demonstrate that 
mitochondrial transport in myelinated P0-CNS axons is impaired 
and preferentially affected in distal juxtaparanodal regions.
MT organization and stability in P0-CNS 
optic nerve axons
MTs are the substrate for fast axonal transport of mitochon-
dria (Hollenbeck and Saxton, 2005). The EM data described 
in Fig.  2 (J–L) support normal MT orientations and densi-
ties in 1-mo-old P0-CNS optic nerves. To investigate whether 
MT organization was affected in distal paranodal axoplasm 
of older P0-CNS axons, we examined 6-mo-old WT and P0-
CNS axons with high-voltage EM tomography. MTs in WT 
nodal and paranodal axoplasm were parallel to each other 
and the longitudinal orientation of the axon (Fig.  5  A). In 
contrast, paranodal MTs in the P0-CNS optic nerve axon 
(Fig. 5 B) had significantly shorter lengths (620 nm vs. 1,856 
nm in WT) and greater curvature, including some that turned 
180°. Thus, MT lengths in P0-CNS optic nerve axons were 
reduced threefold compared with control nerves (Fig. 5 C). 
Reduced MT stability appears to play a role in paranodal 
axonal pathology in 6-mo-old P0-CNS optic nerves. MTs can 
exist as stable polymers of α/β-tubulins with long assembly/
disassembly half-lives, or they can rapidly cycle between de- 
and repolymerization states. The insoluble/soluble acetyl-
ated α-tubulin ratio, which is considered to be an indication 
of MT stability (Schulze et al., 1987; Baas and Black, 1990), 
was similar (∼0.8) in 1- and 6-mo-old WT and 1-mo-old P0-
CNS optic nerves. In contrast, this ratio was significantly 
decreased in 6-mo-old P0-CNS optic nerves (Fig.  5  D). 
These data indicate a decrease in MT stability in 6-mo-old 
P0-CNS optic nerve axons.
Tau phosphorylation is increased in 
P0-CNS axons
Axonal MT stability is also mediated by the MT-binding pro-
tein Tau. Tau stimulates MT polymerization, promotes MT 
stabilization, and modulates binding of kinesin and dynein 
to MTs (Hasegawa, 2006). Tau–MT binding is inhibited by 
phosphorylation within and adjacent to multiple MT-binding 
domains (Bramblett et al., 1993). We compared the levels of 
phosphorylation at four tau residues in optic nerve homog-
enates from 6-mo-old WT and P0-CNS mice (Fig. 5 E) and 
detected a two- to threefold increase in the phosphorylation 
of Ser396 and Ser199/Ser202 in P0-CNS samples (Fig. 5 F). 
Phospho-Ser396 tau flanks MT-binding repeats and modulates 
Figure 4. Increased vulnerability to energy deprivation and altered mi-
tochondrial transport in optic nerves from P0-CNS mice. (A) Recordings 
of CAPs in 1-mo-old P0-CNS mice (orange circles, n = 4) showed a rapid 
loss of CAPs and reduced recovery after 30 min of OGD compared with 
age-matched controls (green circles, n = 6). The inset bar graph summa-
rizes recovery at the end of 2  h after OGD exposure. *, P = 0.026. 
(B) ATP levels were reduced in optic nerves from 1-mo-old P0-CNS mice 
compared with controls. ATP levels were corrected to protein and normal-
ized to WT controls. *, P = 0.015. (C–F) In organotypic slice cultures, 
mitochondrial transport was altered in myelinated P0-CNS axons. (C and 
D) Node locations were identified after time-lapse imaging by immunos-
taining for Caspr (green) and registered to axonal Mito-Dendra2 labeling 
(red). Live time-lapse images of mitochondria (C′ and D′) are converted to 
kymographs (C″ and D″), where cessation of mitochondrial transport is 
frequently observed in P0-CNS axons (P0; D″, arrowheads). Bars: (horizon-
tal) 10 µm; (vertical on kymograph) 100 s. (E) The mean speed of motile 
mitochondria was significantly reduced in P0-CNS axons compared with 
WT axons over the entire axon segment studied (All) and within internodal 
(Inter) and nodal–paranodal axoplasm (N-PN). The mean mitochondrial 
speed in P0-CNS axons was significantly reduced in nodal–paranodal ax-
oplasm compared with internodal axoplasm. Bars and lines are mean + 
SEM. n = 27, 28, 23, 27, 22, and 24. (F) Mitochondrial stopping events 
were quantified in proximal (Prox) and distal (Dis) regions of the nodes. 
Stopping events were more common in the proximal juxtaparanode in WT 
axons and in the distal juxtaparanodal axoplasm in P0-CNS axons. Bars 
with boxes and lines are median, interquartile range, and maximum/min-
imum. *, P < 0.05; ***, P < 0.001; t test; n = 32 and 23 (F) axons from 
three WT and three P0-CNS explants. 
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MT binding (Bramblett et al., 1993; Johnson and Stoothoff, 
2004; Schneider and Mandelkow, 2008). Whole optic nerve 
biochemical analysis may include other sources of tau, in-
cluding oligodendrocytes (Anderson et al., 2008, 2010). We 
colocalized phospho-Ser396 and phospho-Ser202 with the ax-
onal markers tubulin-βIII or neurofilament and confirmed that 
they were enriched in axonal swellings in P0-CNS optic nerves 
(Fig. 5 G). Thus, tau hyperphosphorylation may contribute to 
MT instability in paranodal axonal swellings.
Multiple kinases can phosphorylate tau (Ferrer et al., 
2005; Schneider and Mandelkow, 2008), including the β sub-
unit of glycogen synthase 3 (GSK3) and CDK5. In Western 
blots, the GSK3 isoform (GSK3-β) and phosphorylation of 
GSK3-β at Ser9 were similar in 1-mo-old WT and P0-CNS 
optic nerves. In contrast, levels of GSK3-β subunits were sig-
nificantly increased in 6-mo-old P0-CNS optic nerves, whereas 
GSK3-β phospho-Ser9 levels were significantly reduced 
(Fig. 5, H and I). Because GSK3 phosphorylation inactivates 
GSK3 kinase activity, elevated levels of GSK3 and reduced 
GSK3 phosphorylation in P0-CNS optic nerves are consis-
tent with increased GSK3 activity and tau phosphorylation. 
CDK5 was also increased in 6-mo-old P0-CNS optic nerves 
(Fig. 5, H and I). GSK3-β and CDK5 were enriched in axon 
ovoids in P0-CNS optic nerves (Fig. 5 J). GSK3-β and GSK3-β 
phospho-Ser9 staining were faint in normal-appearing axons 
and present in glial processes. GSK3-β phospho-Ser9 staining 
was found in glial processes but not in P0-CNS axonal ovoids 
(Fig. 5 J), which supports increased GSK3-β kinase activity.
Discussion
Our results implicate mitochondrial degeneration and decreased 
mitochondria–SER associations as primary causes of axonal 
degeneration in a rodent model of inherited myelin disease. 
Decreased ATP levels, reduced mitochondrial cristae, and de-
creased recovery from OGD associate decreased axonal energy 
metabolism with these mitochondrial pathologies. Reduced 
mitochondria–SER associations implicate altered Ca2+ homeo-
stasis as an additional contributor to juxtaparanodal axonal 
pathology in 1-mo-old P0-CNS optic nerves. Collectively, our 
results support the concept that oligodendrocytes sustain axo-
nal viability by providing ATP substrates to the paranodal axo-
plasm and that reduced energy production is the likely cause of 
axonal degeneration in P0-CNS mice. Although the molecular 
mechanism responsible for this metabolic coupling remains to 
be established, it is likely to involve multiple oligodendrocyte/
myelin proteins, including those that cause HSP (PLP, MAG, 
connexin 47, and fatty acid 2-hydroxylase).
Loss of PLP function causes axonal degeneration in both 
mouse and human. We consider loss of PLP function as the under-
lying cause of axonal pathology in P0-CNS optic nerves. The ac-
celerated rate of axonal degeneration in P0-CNS mice (compared 
with PLP-null mice) is the result of an increase in juxtaparanodal 
regions caused by shorter myelin internodes (Yin et al., 2006). 
Mice with both PLP and P0 have normal life spans and no axonal 
pathology (Yin et al., 2006), so it is unlikely that P0 expression 
in CNS myelin directly impacts axonal viability. Expression of 
Figure 5. MT organization and stability are altered in mature P0-CNS optic nerve axons. (A) Axonal MTs in 3D EM tomograms of 6-mo-old WT optic 
nerves are straight and oriented parallel to the longitudinal axis of the axon. (B) MTs in 6-mo-old P0-CNS optic nerves are disorganized. (C) MT lengths 
in P0-CNS optic nerve axons are decreased threefold compared with MT lengths in WT axons (P < 0.00000001). n = 46 and 566 MTs (WT and P0-
CNS). (D) The soluble/insoluble tubulin ratio, an indicator of MT stability, declines with age in P0-CNS mice. n = 3, 3, 6, and 6 preps (1 mo WT, 1 mo 
P0-CNS, 6 mo WT, and 6 mo P0-CNS). (E–G) Quantification and localization of phosphorylated tau epitopes in 6-mo-old WT and P0-CNS optic nerve 
samples. (E and F) The phospo-tau epitopes, Ser199–202, Ser396, and Ser404, were decreased two- to threefold in P0-CNS samples (pooled samples 
analyzed by Kinexus; see Materials and methods). (F) Single pooled samples are from 10 WT and 20 P0-CNS nerves. (G) Double immunofluorescent 
labeling for the axonal marker Tuj1 (tubulin-βIII; green) and either the phospho-tau epitope Ser396 (red) or Ser199/202 tau (red) localized these 
phospho-tau epitopes in axonal ovoids. (H–J) Quantification and localization of GSK3-β, GSK3-β phospho-Ser9, and CDK5 in 6-mo-old WT and P0-CNS 
optic nerves. (H and I) GSK3-β was increased and GSK3-β phospho-Ser9 was decreased in P0-CNS optic nerves. CDK5 levels were also increased in 
P0-CNS optic nerves. (C, D, and I) Bars and lines are mean + SEM. ***, P < 0.001; t test. n = 3 and 3 preps (WT and P0-CNS). (J) Staining of 6-mo-old 
P0-CNS optic nerve sections with neurofilament (NF; green), Tuj1 (tubulin-βIII; green), GSK3-β (red), and CDK5 (red). Expression of GSK3-β (red) and 
CDK5 (red) was enriched in ovoids. GSK3-β phospho-Ser9 (red) was not detected in ovoids. (G and J) Bars, 5 µm.
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P0 in the absence of PLP, however, does induce the formation of 
SLIs in optic nerve myelin internodes (Yin et al., 2008). SLIs, 
which are small cytoplasmic channels that connect outer and 
inner margins of the myelin sheath, are prominent features of 
mammalian peripheral nervous system myelin but are normally 
absent from CNS myelin internodes. In adult P0-CNS optic nerve 
axons, axoplasm beneath SLIs can contain occasional accumu-
lations of mitochondria (Yin et al., 2008). Mitochondria did not 
accumulate in axoplasm beneath SLIs in 1-mo-old P0-CNS optic 
nerves (Fig. S1, A and B). Although SLIs may contribute to ax-
onal pathology in adult P0-CNS optic nerves, they do not appear 
to impact mitochondrial viability in 1-mo-old P0-CNS mice. Be-
cause SLIs are not a feature of PLP-null optic nerves, they can 
contribute to, but are not essential for, CNS axonal pathology.
The pathological hallmark of P0-CNS myelinated axons 
is accumulation of axonal organelles at distal juxtaparan-
odes. Our data suggest that this late-onset axonopathy (6–9 
mo) is a consequence of reduced ATP production and of mi-
tochondrial degeneration that is apparent at 1 mo of age. MT 
pathology prominent at 6 mo (decreased length, decreased 
stability, altered orientation, and increased phosphorylated 
tau) was not present at 1 mo of age. Accumulation of small 
vesicles, which is a prominent feature of 6-mo-old P0-CNS 
juxtaparanodal axoplasm (Fig. S1 C), was not present in 
1-mo-old P0-CNS juxtaparanodal axoplasm (Figs. 1 E, 2 B, 
and 3, D, I, and K). Vesicular fast axonal transport is fueled 
by the glycolytic enzyme GAP DH, which binds to and trav-
els with axonal vesicles in a huntingtin-dependent fashion 
(Zala et al., 2013). The dissociation of vesicular transport 
from mitochondrial respiration assures fast vesicular trans-
port in axoplasm devoid of mitochondria. In contrast, nodal 
function depends on mitochondrial respiration and oligo-
dendrocyte-derived ATP substrates. The juxtaparanodal en-
richment of mitochondrial pathology and ovoid formation in 
HSP reflects the high-energy demand of saltatory conduc-
tion and the select vulnerability of juxtaparanodal mitochon-
dria to mutations in myelin genes.
Stationary mitochondria were increased in 1-mo-old 
P0-CNS paranodal axoplasm (Fig.  4). Two events could 
provide a possible mechanism for stationary mitochondrial 
generation in juxtaparanodal axoplasm. First, juxtaparan-
odal axonal mitochondria could undergo fission and increase 
the mitochondrial number. Second, increased stopping of 
transported motile mitochondria at distal juxtaparanodes 
(as demonstrated by our time-lapse imaging experiments; 
Fig.  4) and their fusion with mitochondria could increase 
mitochondrial volume. As previously demonstrated for de-
myelinated axons (Kiryu-Seo et al., 2010; Ohno et al., 2011, 
2014), P0-CNS axons may increase mitochondrial volume in 
juxtaparanodal axoplasm as a response to increased energy 
demands caused by mitochondrial degeneration and reduced 
ATP production. Degenerating mitochondria are displaced to 
peripheral juxtaparanodal axoplasm and increase axonal di-
ameter (Fig. 2). When neurofilaments accumulate in axons as 
the result of ββ′-iminodipropionitrile toxicity, they are also 
displaced to the peripheral axoplasm (Griffin et al., 1978). 
Peripheral displacement of altered axonal organelles ap-
pears to be a mechanism used by axons to maintain a central 
core of normal axoplasm.
Recent studies support the concept that MCT1, which 
is enriched in myelin paranodes, releases lactate that is inter-
nalized into paranodal axoplasm and used by mitochondria 
for oxidative metabolism and ATP biosynthesis (Fünfschil-
ling et al., 2012; Lee et al., 2012; Morrison et al., 2013, 
2015; Saab et al., 2013; Hirrlinger and Nave, 2014). Atten-
uation of MCT1 levels in vivo and in vitro results in axonal 
degeneration (Lee et al., 2012). Pharmacological inhibition 
of MCT1 in organotypic slice cultures also causes axonal 
degeneration, which can be rescued by adding free lactate 
to the culture medium (Lee et al., 2012). Because lactate 
transfer cannot be directly measured, sorting primary and 
secondary effects of lactate deficiency in the environment 
of mitochondrial degeneration will require manipulation of 
MCT1 function in oligodendrocytes.
Mitochondrial dysfunction and increased intraaxonal 
Ca2+ are considered to be convergent mechanisms of axo-
nal degeneration in chronic neurodegenerative diseases 
(Coleman, 2005). The ability to reconstruct mitochondria 
and SER in WT and P0-CNS axons at nanometer resolution 
allowed us to identify and expand previously described ex-
tensions of the mitochondrial outer membrane (Spacek and 
Lieberman, 1980). Approximately 70% of WT optic nerve 
axonal mitochondria had extensions of their outer mem-
brane, which increased mitochondrial length and mitochon-
dria–SER associations by 66%. Sites of close opposition 
between mitochondria and SER are referred to as the mito-
chondria-associated ER membrane (MAM; Hayashi et al., 
2009). Although the molecular composition of the MAM 
is not fully characterized, the SER MAM contains several 
Ca2+-binding chaperones (Hayashi et al., 2009). It is pos-
sible that mitochondrial outer membrane extensions have a 
unique molecular signature that reflects specialized or en-
hanced MAM functions. In support of a specialized func-
tion, not all CNS axons have mitochondrial outer membrane 
extensions. Originally described in CNS axons (Spacek and 
Lieberman, 1980), they are abundant in optic nerves and rare 
in the corpus callosum and cerebellar axons (Ohno et al., 
2011, 2014). They are not common in rodent liver (Ohno 
et al., 2014) but are a prominent feature of mitochondria in 
Sertoli cells (Rashed, 2010). Mitochondria in 1-mo-old P0-
CNS paranodal axoplasm rarely extended their outer mem-
branes, and the SER was fragmented. The 86% reduction 
in mitochondria–SER associations in P0-CNS axons may 
alter Ca2+ buffering and play a pivotal role in juxtaparan-
odal axonal dysfunction.
Paranodal axonal swellings are a pathological hall-
mark of HSPs caused by protein mutations that are enriched 
in myelin and axonal organelles (mitochondria, MTs, and 
SER; Blackstone, 2012). Axon ovoids are also a common 
feature in peripheral nerves from individuals with Charcot- 
Marie-Tooth disease. Charcot-Marie-Tooth is caused by mu-
tations in neuronal or Schwann cell genes and is considered 
to be the peripheral nerve equivalent of HSP (Timmerman et 
al., 2013). Correlations between mutated genes and protein 
network analysis have also identified significant overlap be-
tween HSP genes and genes implicated in amyotrophic lat-
eral sclerosis, Alzheimer’s disease, and Parkinson’s disease 
(Novarino et al., 2014). The major objective of this study was 
to elucidate the mechanism responsible for axonal degener-
ation in P0-CNS mice. Mitochondrial degeneration, reduced 
mitochondria–SER associations, and reduced ATP produc-
tion are prominent features of axonal degeneration in P0-CNS 
axons and may drive aspects of axonal degeneration in a 
variety of CNS diseases.
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Materials and methods
Animals
We generated transgenic mice that expressed mouse P0 cDNA (Lemke 
and Axel, 1985) ligated to a 9.1-kb region of the mouse myelin basic 
protein promoter. This line has equal amounts of P0 and PLP in CNS 
myelin (PLP/P0-CNS mice; Yin et al., 2006). By crossing PLP-null 
mice with PLP/P0-CNS mice, we obtained mice that were null for PLP 
and homozygous for the P0 transgene (P0-CNS). These mice have been 
described in detail previously (Yin et al., 2006) and consist of B6129F1 
(PLP null), FVB (PLP/P0-CNS mice), and B6129F1/FVB (P0-CNS) 
backgrounds. Because the PLP gene is X linked, our experiments only 
included male P0-CNS mice. WT male mice were used as controls and 
were of the same genetic background as P0-CNS mice.
3D EM reconstruction using serial blockface scanning EM
Tissue preparation and imaging were performed as previously de-
scribed (Ohno et al., 2011) using en block staining methods (Deerinck 
et al., 2010). In brief, P0-CNS and WT mice at 1 and 6 mo of age were 
perfused with 0.1-M sodium cacodylate buffer containing 2.5% glutar-
aldehyde (Electron Microscopy Sciences) and 4% paraformaldehyde. 
Optic nerves were dissected, cut into 5-mm segments, postfixed in 
0.1% tannic acid in buffer, washed, and then stained successively with 
osmium ferricyanide, tetracarbohydrazide, aqueous osmium tetroxide, 
saturated aqueous uranyl acetate, and Walton’s lead aspartate stains, 
as described previously (Deerinck et al., 2010). Tissues were then de-
hydrated in graded ethanols and embedded in Procure 812 embedding 
resin at 60°C for 48 h.
Nerve segments were mounted on aluminum pins, trimmed, 
surrounded with silver paste, and examined in a Sigma VP scanning 
electron microscope (ZEI SS) fitted with a 3View in-chamber ultra-
microtome (Gatan) and a low-kilovolt backscattered electron detector 
(Gatan). Longitudinally oriented axons were imaged covering areas 
∼80 µm wide and 80–400 µm in length. Images were collected at 1.8–
2.5 kV, depending on tissue contrast, and up to 500 slices were cut 
at a thickness of 40–100 nm. Imaging was conducted using a 30-µm 
aperture in high-current mode and imaged at room temperature (21°C 
at a chamber vacuum of 10−6 mbar and working distance of 5.7 mm).
Images were reconstructed and registered using ImageJ/FIJI 
software (National Institutes of Health). Axons, SER, and mitochon-
dria were segmented in each slice by a combination of signal inten-
sity–based thresholding and manual segmentation using ImageJ with 
FIJI plugins or Reconstruct software (SynapseWeb; Fiala, 2005) and 
rendered using Blender software or Amira (v. 5.5.0; FEI Visualization 
Sciences Group), as described previously (Ohno et al., 2011). Volumes 
were calculated as the sum of areas in each slice multiplied by the 
slice thickness. Lengths were measured as 3D distances using polyline 
tools. Axonal and mitochondrial mean diameters were calculated using 
length and volume and assuming a cylindrical geometry. SER asso-
ciated with the mitochondrial surface was measured as the length of 
SER within 50 nm of the mitochondrial surface. SER termini (SER 
fragmentation) were counted manually on projection images of a 5-µm-
long segment of axon and expressed as termini per SER volume. Re-
constructed single-slice views were assembled from multiple regions of 
interest obtained along a user-defined path through the stack (x, y, and 
z coordinates), e.g., along an axon centerline.
MT stability assay and Western blots
WT and P0-CNS optic nerves from 1- and 6-mo-old mice were ho-
mogenized and lysed in an MT stabilization buffer containing 100 mM 
Pipes, pH 6.9, 5 mM MgCl2, 1 mM EGTA, 30% glycerol, 0.1% Nonidet 
P-40, 0.1% Triton X-100, 0.1% Tween 20, 0.1% β-mercaptoethanol, 
0.001% antifoam, 1 mM dithiothrietol, 1 mM GTP, 10 mM ATP, 10 µM 
Taxol, and 10 µl protease inhibitor cocktail (Cytoskeleton, Inc.). After 
centrifugation at 100,000 g for 30 min, supernatants containing solu-
ble tubulin were separated from pellets containing polymerized tubu-
lin. The pellets were dissolved in double-distilled deionized water for 
Western blotting with acetylated α-tubulin antibodies (mouse mono-
clonal; Sigma-Aldrich). Data are expressed as the insoluble/soluble 
acetylated α-tubulin ratio.
Phospho-site–specific kinase screening was performed by Ki-
nexus Bioinformatics Corp. using antibody microarrays. Pooled sam-
ples from 20 (1 mo old) and 10 (6 mo old) optic nerves from WT and 
P0-CNS mice were collected and submitted to Kinexus for antibody 
microarray (KAM-1.3) testing using 500 Pan-Ab and 300 Phospho-Ab, 
which included phosphorylation states of tau and kinases. Analysis was 
undertaken using the KPSS 9.1 program by Kinexus.
Western blotting was performed on WT and P0-CNS optic nerves 
homogenized in 10 volumes of Tris-buffered saline containing 1 mM 
EDTA, 1 mM PMSF, and protease and phosphatase inhibitors (Sigma- 
Aldrich). Protein concentrations were determined by protein assays 
(Bio-Rad Laboratories). Proteins were separated on 4–12% NuPAGE 
MES gels (Thermo Fisher Scientific) and then transferred onto poly-
vinylidene fluoride membranes. Primary antibodies for Western blots 
included GSK3-αβ (mouse monoclonal; Enzo Life Sciences), 3β-pSer9 
(rabbit polyclonal; Cell Signaling Technology), and Cdk5 (mouse 
monoclonal; EMD Millipore), with GAP DH as a loading control.
Immunocytochemistry
6-mo-old WT and P0-CNS mice were perfused with 4% paraformal-
dehyde. Optic nerves were removed, fixed overnight, and then cut at a 
thickness of 10 µm in a cryostat (Leica Biosystems). Sections were dou-
ble immunostained for axons with Neurofilament-H (rabbit polyclonal; 
AbD Serotec) or tubulin-βIII (TUJ1; mouse monoclonal; Covance) 
and GSK3-αβ (mouse monoclonal), GSK3β-pSer9 (rabbit polyclonal), 
tau–phospho Ser396, tau–phospho Ser202 (rabbit polyclonal; Abcam), 
or Cdk5 (mouse monoclonal). Secondary antibodies were Alexa Fluor 
488 or Alexa Fluor 594 conjugated (Invitrogen). Confocal images were 
collected using an SP5 confocal microscope (Leica Biosystems) using 
a 63× 1.4 NA oil immersion lens and acquiring images at room tem-
perature using 488-nm and 561-nm laser lines and 1,024 × 1,024 pixel 
formats. Step sizes of 0.5 µm were used for z series acquisition. Images 
were reconstructed using ImageJ/FIJI software.
High-voltage transmission electron microscope tomography
WT and P0-CNS mice were perfused with 4% paraformaldehyde and 
2.5% glutaraldehyde. Semi-thin serial sections (0.5 µm) of optic nerves 
were cut, placed on formvar-coated slotted grids, and stained with 1% 
uranyl acetate and 1% lead citrate. 3D reconstructions of axonal contents 
were collected as previously described (Perkins et al., 2008). In brief, for 
each reconstruction, a series of images at regular tilt increments was col-
lected with a 4000EX intermediate-voltage electron microscope (JEOL 
USA) operated at 400 kV. Tilt series were recorded on film at ×20K at 
2° angles from −60° to 60°. Negatives were digitized to produce images 
with 1.41 nm/pixel. The IMOD package (Kremer et al., 1996) was used 
for rough alignment, with fine alignment and reconstruction performed 
using the TxBR package (Lawrence et al., 2006). Volume segmentation 
was performed by manual tracing using Xvoxtrace (Perkins et al., 1997), 
and reconstructions were visualized using Analyze (Mayo Foundation), 
Synu (Hessler et al., 1996), and Amira (Mercury/TGS) software.
Preparation of optic nerves, recording techniques, and OGD
These procedures were performed as previously described (Baltan et 
al., 2010, 2011, 2013). In brief, mouse optic nerves were obtained from 
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1-mo-old P0-CNS and WT mice and placed in a perfusion chamber 
superfused with artificial cerebrospinal fluid (ACSF) and continuously 
aerated by a humidified gas mixture of 95% O2/5% CO2. All exper-
iments were performed at 37°C.  Suction electrodes back-filled with 
ACSF were used for stimulation (Isostim 520; WPI) and for record-
ing the CAP. The recording electrode was connected to an amplifier 
(Axoclamp 900A; Molecular Devices), and the signal was amplified 50 
times, filtered at 30 kHz, and acquired at 20–30 kHz. Axon pClamp 10 
software (Molecular Devices) was used for data acquisition. Stimulus 
pulse (50-µs duration) strength was adjusted to evoke the maximum 
CAP and then increased another 25% for supramaximal stimulation. 
The supramaximal CAP was elicited every 30 s. OGD stress was in-
duced by switching to glucose-free ACSF (replaced with equimolar 
sucrose to maintain osmolarity) and a gas mixture containing 95% 
N2/5% CO2. OGD was applied for 30 min, ACSF and O2 were restored, 
and CAPs were recorded for up to 5 h after the end of OGD. Optic 
nerve function was monitored quantitatively as the area under the su-
pramaximal CAP. Original data were normalized by setting the mean 
of initial baseline values (measured over 15 min) to a value of 1.0. Re-
sults from several nerves were pooled, averaged, and plotted against 
time. All data are presented as the mean ± SEM. Statistical signifi-
cance was determined by unpaired two-tailed Student’s t tests or anal-
yses of variance (ANO VAs). ANO VAs were followed by Bonferroni’s 
post-hoc test (Prism 4; GraphPad Software). The n values indicate the 
number of optic nerves.
ATP measurements
ATP extraction was performed as previously described (Khan, 2003) 
and modified for optic nerve as described in previous publications (Bal-
tan et al., 2010, 2011). In brief, nerves were diced and placed in 75 µl of 
10% perchloric acid (HClO4), sonicated, and centrifuged at 4,500 rpm 
for 10 min at 4°C. The supernatant was neutralized with 30 µl of 2.5 M 
potassium hydroxide (KOH) and centrifuged at 14,000 rpm for 10 min 
at 4°C. Total cellular ATP was measured using a bioluminescence assay 
kit (11 699 709 001; Roche). The absorbance was measured at 560 nm. 
The blank values were subtracted from the raw data, and ATP concen-
trations were calculated from a log–log plot of the standard curve and 
were normalized to protein concentration. The values are expressed as 
micromoles of ATP per milligram of protein. Protein content was quan-
tified in one nerve, and ATP levels were measured in the other.
Myelinating organotypic cerebellar slice cultures
Tissue preparation and imaging were performed as previously de-
scribed (Ohno et al., 2011). Myelinating organotypic cultures were 
generated from 150–200-µm-thick slices of P8-10 cerebellum from 
WT and P0-CNS mice (Dusart et al., 1997). The slices were cul-
tured on Millicell organotypic culture inserts (EMD Millipore) in 
6-well plates containing 50% minimal essential medium, 25% horse 
serum, 25% HBSS, 6 mg/ml d-glucose, 1× Glutamax (Invitrogen), 
and penicillin/streptomycin. 2  h after plating, the lentiviral vectors 
were injected into the Purkinje cell layer using a glass microinjection 
needle (Kasri et al., 2008).
Lentivirus with mitochondria-targeted Dendra2 was prepared 
using a pLenti6/V5 directional TOPO cloning kit (Invitrogen) accord-
ing to the manufacturer’s protocol with slight modifications (Hirai, 
2008). In brief, 293FT cells were transfected with pLentiV5/6 lenti-
viral vector including Mito-Dendra2 (Takara Bio Inc.) and packag-
ing plasmids. The medium was changed 4  h after the transfection. 
Viral supernatants were collected 24 h after the transfection, filtered 
with 0.22 µm polyvinylidene fluoride membrane (EMD Millipore), 
and centrifuged at 100,000 g for 2 h. The viral pellet was suspended 
in a 1/100 volume of PBS.
Purkinje cell axons with Dendra2-positive mitochondria were 
imaged by confocal microscopy as reported previously (Ohno et al., 
2011). Glass-bottom dishes with culture medium and pieces of Milli-
cell membrane with attached slices were transferred into a microincu-
bator (PDMI-2; Medical System) attached to an inverted laser-scanning 
confocal microscope (TCS SP; Leica Biosystems). The slices were il-
luminated with 488-nm light through a 40× oil immersion objective 
(NA 1.21; Leica Biosystems). Images of mitochondria were collected 
at 1,024 × 1,024 pixel resolution every 6 s. Imaging at 6-s intervals did 
not induce mitochondrial fragmentation, acute mitochondrial swelling, 
or cessation of axonal transport.
Kymographs of mitochondria in time-lapse images were pro-
duced using ImageJ as described previously (Miller and Sheetz, 2004). 
Motile mitochondria were identified as moving diagonal lines in kymo-
graphs. Mean velocity of motile mitochondria was measured by divid-
ing total displacement distance by total time in juxtaparanodal (<15 µm 
from nodes) and internodal (15–40 µm from nodes) axoplasm. After 
time-lapse imaging, slices were fixed with buffered 4% paraformalde-
hyde for 6 h and immunostained for Caspr to establish the location of 
the paranodal/nodal axoplasm (Ohno et al., 2011). The immunostained 
images were coregistered with kymographs, and stopping events were 
quantified in proximal and distal juxtaparanodal regions (∼2.5–17.5 
µm from the center of nodes).
Statistical analysis
Mitochondrial size, shape, and volume data were tested for normal 
distributions using the Kolmogorov-Smirnoff test (α = 0.05). Where 
normally distributed, groups were compared using ANO VAs and 
two-tailed Student’s t tests with Bonferroni’s correction for multiple 
comparisons where appropriate. Kruskal-Wallis comparisons and Wil-
coxon signed-rank tests (two-tailed with Bonferroni corrections to α 
levels for multiple comparisons) were used for nonparametric data. 
Mitochondrial pathology categorical data were compared between 
groups using Fisher’s exact test. Statistical testing was performed using 
R or SigmaStat software.
Online supplemental material
Fig. S1 shows electron micrographs of optic nerve axons from 1- and 
6-mo-old P0-CNS mice. Fig. S2 shows how mitochondrial outer mem-
brane extensions increase mitochondria–SER associations in optic 
nerve axons from 1-mo-old mice. Table S1 shows the percentage of 
mitochondria with normal and pathological morphologies (Fig. 2, E–I) 
bearing outer membrane extensions.
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